A detailed history of Marshall Wace, LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 3,360 shares of MRK stock, worth $336,201. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,360
Previous 2,584,183 99.87%
Holding current value
$336,201
Previous $320 Million 99.88%
% of portfolio
0.0%
Previous 0.44%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $287 Million - $333 Million
-2,580,823 Reduced 99.87%
3,360 $381,000
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $78.5 Million - $84.3 Million
634,194 Added 32.52%
2,584,183 $320 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $231 Million - $269 Million
-2,039,971 Reduced 51.13%
1,949,989 $257 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $194 Million - $211 Million
1,938,555 Added 94.5%
3,989,960 $435 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $193 Million - $214 Million
1,875,318 Added 1065.0%
2,051,405 $211 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $19.1 Million - $20.8 Million
176,087 New
176,087 $20.3 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $32.6 Million - $41.8 Million
372,519 Added 56.33%
1,033,806 $115 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $435 Million - $488 Million
-5,140,458 Reduced 88.6%
661,287 $57 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $82.1 Million - $93.1 Million
-983,823 Reduced 14.5%
5,801,745 $529 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $496 Million - $556 Million
6,746,481 Added 17260.17%
6,785,568 $557 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $2.64 Million - $3.31 Million
36,573 Added 1454.77%
39,087 $3 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $180,203 - $198,178
2,514 New
2,514 $189,000
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $3.73 Million - $4.39 Million
-54,136 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $14.8 Million - $16.5 Million
-206,854 Reduced 79.26%
54,136 $4.43 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $7.13 Million - $8.08 Million
97,378 Added 59.52%
260,990 $21.7 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $11.1 Million - $12.7 Million
-158,205 Reduced 49.16%
163,612 $12.7 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $2.07 Million - $2.87 Million
-32,736 Reduced 9.23%
321,817 $24.8 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $11.5 Million - $13 Million
147,992 Added 71.65%
354,553 $32.2 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $19.6 Million - $21.4 Million
-257,708 Reduced 55.51%
206,561 $17.4 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $17.1 Million - $19.9 Million
244,145 Added 110.91%
464,269 $38.9 Million
Q1 2019

May 14, 2019

BUY
$69.58 - $79.36 $5.99 Million - $6.84 Million
86,159 Added 64.31%
220,124 $18.3 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $4.62 Million - $5.37 Million
70,868 Added 112.32%
133,965 $10.2 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $1.71 Million - $2.01 Million
29,699 Added 88.92%
63,097 $4.48 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $1.7 Million - $1.99 Million
33,398 New
33,398 $2.03 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.